Speaker illustration

Professor Lisa Jennings

MLM Medical Labs, LLC, Memphis (United States of America)

Member of:

European Society of Cardiology

Dr. Jennings, Founder and CEO of CirQuest Labs, merged in 2020 with MLM Medical Labs, LLC, as a unique, science-driven research and clinical trial services laboratory with expertise in broad therapeutic areas. With the pharmaceutical and devices industries, MLM provides innovative solutions for drug and device development challenges from the nonclinical assay development/validation stage through Phase I-III sample testing. Dr. Jennings serves as a Clinical Professor at the University of TN Health Science Center in the Department of Internal Medicine. As a tenured faculty and MLM executive, Dr. Jennings has published >250 peer-reviewed publications and abstracts, and has been an invited speaker to more than 200 institutions, scientific meetings, and industry-sponsored events. Her work, in collaboration with colleagues, has advanced the understanding of the biology of hemostasis and thrombosis including the characterization of anti-thrombotic therapies and reversal agents.

Evaluation of the pharmacodynamics of a ticagrelor reversal agent PB2452

Event: ESC Congress 2019

Topic: Antiplatelet Drugs

Session: New developments in anti thrombotic drug therapy


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb